“…This lack of success can be attributed to the fact that the current in vivo scoring system provides very descriptive and subjective information (13,17,19 (12,13,(17)(18)(19). And second, changes in types and/or levels of biomarkers, cytokines or extracellular factors, will reflect differences in the extent of initial damage (i.e., area and depth of injury) ; the initial responses (e.g., edema, neutrophilic infiltrate) ; and the eventual repair processes (e.g., neovascularization, epithelial regeneration, collagen deposition) (17)(18)(19). Further, these biomarkers can be applied to in vitro systems as predictors of eye irritation (17)(18)(19) (12,13,17).…”